COVID-19_Link_Button.jpg

COVID19

About Us

Our Providers

AFIB Center

Testing & Procedures

Vein Treatment Center

Patient Resources

Locations

Patient Portal

News/Blog

Contact Us

BGMC/GVI Implants TriClip™ DeviceBuffalo General Medical Center/Gates Vascular Institute is one of the first 15 sites nationwide and the first hospital in Western New York to have commercial access to TriClip™, which marks a revolutionary shift in treating patients with a leaky tricuspid valve, or tricuspid regurgitation (TR), eliminating the need for open-heart surgery. TriClip™ stands as the first FDA-approved therapy of its kind, boasting unparalleled safety and efficacy for patients.

“The introduction of the TriClip™ TEER system represents a significant advancement in our ability to combat tricuspid regurgitation, a condition historically fraught with limited treatment options and significant risks,” said Dr. Vijay Iyer, MD, PhD, Director of Interventional Cardiology at Kaleida Health and interventional cardiologist with General Physician, PC. “By offering a minimally-invasive alternative to traditional open-heart surgery, the TriClip™ device not only mitigates the burdensome symptoms associated with TR but also marks a new era in precision medicine. This first successful implantation underscores the transformative potential of cutting-edge technologies in reshaping the landscape of cardiovascular care, reaffirming our commitment to delivering the highest standard of care to our patients."

TriClip™ is seamlessly delivered to the heart via a catheter inserted through the femoral vein in the leg. Its mechanism involves delicately clipping together a segment of the tricuspid valve leaflets, mitigating the backward flow of blood. Tailored for the intricacies of the right side of the heart and the tricuspid valve's anatomy, this cutting-edge system empowers physicians to precisely address valve dysfunction, thus optimizing cardiac function and alleviating symptoms of TR, substantially enhancing the quality of life for patients.

Tricuspid valve regurgitation, characterized by improper closure between the right ventricle and right atrium, exacts a heavy toll on individuals, manifesting in debilitating symptoms such as shortness of breath and fatigue. Left untreated, it may precipitate severe conditions like atrial fibrillation (AF) and heart failure, posing potentially fatal risks. Historically, treatment options were limited to high-risk open-heart surgery or ineffective long-term medical therapy. Abbott’s TriClip™ device heralds a much-needed paradigm shift, offering a minimally invasive lifeline to those suffering from TR.

To learn more about the TriClip TEER system, visit buffalogeneral.org.

Great Lakes Cardiovascular

We're Here to Help

If you have any questions about our practice or services, please contact us to speak with a knowledgeable representative.

 

Our Great Lakes Cardiovascular Locations

1091 Main St., Ste. 301
Buffalo, NY 14209
Get Directions » 

100 High St.
Buffalo, NY 14203
Get Directions »

Bradford Regional Medical Center
116 Interstate Parkway, Ste. 21
Bradford, PA 16701
Get Directions »

 

 

3898 Vineyard Dr. Ste. 1
Dunkirk, NY 14048
Get Directions »

5844 Southwestern Blvd., Ste. 100
Hamburg, NY 14048
Get Directions »

475 South Transit Road Ste. 200
Lockport, NY 14094
Get Directions »

 

571 10th Street, Suite 264A
Niagara Falls, NY 14301
Get Directions »

401 North 8th Street
Olean, NY 14760
Get Directions »

515 Main St.
Olean, NY 14760
Get Directions »

 

5959 Big Tree Rd., Ste. 102
Orchard Park, NY 14127
Get Directions »

705 Maple Rd. 
Williamsville, NY 14221
Get Directions »

 

 

S5 Mega Box